Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1985-09-06
1986-12-23
Marantz, Sidney
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
436175, 436177, 436534, 436540, 436804, 436813, 436825, 436826, G01N 3353, G01N 33539, G01N 33541, G01N 33574
Patent
active
046312544
ABSTRACT:
Process for the determination of carcinoembryonic antigen (CEA) in a sample of serum or plasma. The process comprises contacting a slightly acidic buffered sample of the serum or plasma with hydrophilic silica at room temperature, separating the silica from the sample and carrying out a radioimmunoassay for carcinoembryonic antigen on said sample.
REFERENCES:
patent: 3776698 (1973-12-01), Eisentraut
patent: 3852415 (1974-12-01), Vandervoorde
patent: 4056468 (1977-11-01), Breiter
patent: 4140753 (1979-02-01), Edgington
patent: 4180556 (1979-12-01), Kim
patent: 4246351 (1981-01-01), Miyake
patent: 4272504 (1981-06-01), Kim
patent: 4298472 (1981-11-01), Durand
patent: 4299815 (1981-11-01), Hansen
patent: 4467031 (1984-08-01), Gallati
patent: 4578349 (1986-03-01), Schaffel
Giorgio Nicholas A.
Krupey John
Wilson Leonard T.
Gould George M.
Hoffmann-La Roche Inc.
Marantz Sidney
Saxe Jon S.
Tramaloni Dennis P.
LandOfFree
Carcinoembryonic antigen determination does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carcinoembryonic antigen determination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carcinoembryonic antigen determination will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-171672